コロンビア特別区における非小細胞肺癌の臨床試験
コロンビア特別区内の拠点で、非小細胞肺癌に関する38件の研究が参加者を募集しています。
コロンビア特別区内の都市
公式研究テキスト（英語）
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT04267848A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Local Institution - 0183, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07680764Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06472245A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05498428A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- MedStar Georgetown University Hospital, Washington D.C.
- Washington DC VA Medical Center, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06667076A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Georgetown University, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07154290This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Washington DC Veterans Affairs Medical Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06758401Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- MedStar Georgetown University Hospital, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT03191149Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06890598Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
- MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06712316Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Georgetown University Medical Center, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
- George Washington University Cancer Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07195695Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Local Institution - 007-5476, Washington D.C.
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT04613596A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
- MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/10更新 · NCT04302025A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- Washington Hospital Center ( Site 0037), Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06422143Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
- MedStar Georgetown University Hospital, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07288177MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/24更新 · NCT06586515Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06500481A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
- Georgetown University - Lombardi Comprehensive Cancer Center, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT07111520A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
- Georgetown University Medical Center, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06706076Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06449313Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- Georgetown University, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/21更新 · NCT05098132Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Georgetown University Medical Center, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/30更新 · NCT06162221Gilteritinib for the Treatment of ALK NSCLC
- Georgetown University, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/26更新 · NCT06225427Study of XB010 in Subjects With Solid Tumors
- Georgetown University Medical Center, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/22更新 · NCT06545331Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
- Georgetown University Medical Cener (GUMC), Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/19更新 · NCT07154706A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Research Site, Washington D.C.
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/05/14更新 · NCT06417814Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
被験者募集中第2相
18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/16更新 · NCT04499053Repositioning Immunotherapy in VetArans With Lung Cancer
- VA Central Office, Washington, DC, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/02更新 · NCT06275360VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- The George Washington University Cancer Center (site 212), Washington D.C.
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/02更新 · NCT06669117ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。